SCHEMBL30996

SCHEMBL30996

C[Si](C)(C)CCOCS(=O)(=O)N(c1cc(C2CCC(O)(CO)CC2)nc2c(-c3ccc(-c4ccccc4)nc3)cnn12)S(=O)(=O)COCC[Si](C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 5/20 0.37
CHEK1 O14757 2/20 0.34
CCNA2 P20248 2/20 0.34
CDK2 P24941 2/20 0.34
CCNA1 P78396 2/20 0.34
ALOX5AP P20292 2/20 0.33
FEN1 P39748 2/20 0.33
MTOR P42345 3/20 0.33
RPTOR Q8N122 3/20 0.33
MLST8 Q9BVC4 3/20 0.33
NPC1 O15118 3/20 0.31
RAB9A P51151 3/20 0.31
MAPT P10636 3/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
MEN1 O00255 2/20 0.31
KMT2A Q03164 2/20 0.31
STAT1 P42224 2/20 0.31
MAPK1 P28482 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15007079 0.88 DGAT1 (0.38) DGAT1CHEK1CCNA2CDK2CCNA1
SCHEMBL15031603 0.88 DGAT1 (0.38) DGAT1CHEK1CCNA2CDK2CCNA1
SCHEMBL22758 0.88 DGAT1 (0.38) DGAT1CHEK1CCNA2CDK2CCNA1
SCHEMBL22763 0.84 DGAT1 (0.42) DGAT1CHEK1CCNA2CDK2CCNA1
SCHEMBL15007277 0.84 DGAT1 (0.37) DGAT1CHEK1CCNA2CDK2CCNA1
SCHEMBL15007278 0.84 DGAT1 (0.37) DGAT1CHEK1CCNA2CDK2CCNA1
SCHEMBL15007343 0.83 DGAT1 (0.37) DGAT1CHEK1CCNA2CDK2CCNA1
SCHEMBL15007489 0.82 DGAT1 (0.37) DGAT1CHEK1CCNA2CDK2CCNA1
SCHEMBL22266 0.82 DGAT1 (0.37) DGAT1CHEK1CCNA2CDK2CCNA1
SCHEMBL15007488 0.82 DGAT1 (0.37) DGAT1CHEK1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608669-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-07-03 EP disclosed
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 WO disclosed